Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus dosing according to CYP3A5 genotype in kidney transplant recipients
TCTR20131019001Recruiting
- Sponsor
- National Science and Technology Development Agency
- Start
- Jun 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of tacrolimus in Kidney allograft status (RTx), sponsored by National Science and Technology Development Agency. Started Jun 2013; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on TCTR20131019001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20131019001.